A Guideline Development Group (GDG) meeting at the end of the month aims to establish new guidelines for lenacapavir, a twice ...

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to ...

The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...

(Yicai) Jan. 3 -- US pharmaceutical company Gilead Sciences has been given the greenlight by Chinese regulators to sell its ...

Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.

This year saw several advancements across medicine, space technology, and AI that extend our knowledge in consequential ways.

A significant breakthrough in treating the Human Immunodeficiency Virus (HIV) came recently with the US Federal Drug ...

In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an ...

Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...

INR:6474. online sports betting bonus Therapeutic concentration lasts for 6 months! Gilead releases early data on HIV-1 capsid inhibitor Luye Pharmace ...

Lenacapavir has shown high efficacy in managing multidrug-resistant cases offering hope to patients with limited alternatives A significant breakthrough in treating the Human Immunodeficiency Virus HI ...

INR:9416. chhotu dada auto wala Therapeutic concentration lasts for 6 months! Gilead releases early data on HIV-1 capsid inhibitor The National Health Commi ...